We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




RNA Binding Protein Required for Successful Infection by HCMV

By LabMedica International staff writers
Posted on 03 Nov 2016
A team of molecular virologists has catalogued the interactions that occur at the genetic level when cytomegalovirus (HCMV) infects human cells.

Investigators at the University of California, San Diego (USA) performed comprehensive transcriptome-wide analyses to better understand interactions occurring at the post-transcriptional level between the human host and HCMV.

They reported in the October 24, 2016, online edition of the journal Nature Structural and Molecular Biology that the host RNA-binding protein CPEB1 (Cytoplasmic polyadenylation element-binding protein 1) was highly induced after infection. More...
Introduction of CPEB1 into uninfected cells recapitulated the infection-related post-transcriptional changes seen in host cells that had been invaded by HCMV.

CPEB1 was also required for poly(A)-tail lengthening of viral RNAs important for productive infection. Furthermore, depletion of CPEB1 reversed infection-related cytopathology and post-transcriptional changes, and decreased productive HCMV titers.

“We found that CPEB1, one of a family of hundreds of RNA-binding proteins in the human genome, is important for establishing productive cytomegalovirus infections,” said senior author Dr. Gene Yeo, professor of cellular and molecular medicine at the University of California, San Diego. “The next steps are to determine the therapeutic value of inhibiting CPEB1 in HCMV infections and identify other RNA-binding proteins that may be important in other viral infections.”

Related Links:
University of California, San Diego


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Prefilled Tubes
Prefilled 5.0ml Tubes
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.